Skip to main content
. 2017 Jan 19;14:5. doi: 10.1186/s12014-017-9139-z

Table 2.

Insulin levels in 6 human serums tested by chemiluminescence immunoassays (CIA) and the developed immune-MS method

Serums of patients (accepting insulin therapy)
#1 #2 #3 #4 #5 #6
CIA (nM)a 1.0 3.6 3.2 2.1 3.5 2.3
MS (nM)b 1.3 3.8 3.3 2.2 3.8 2.4

5 Duplicates of each sample were tested by MALDI MS based on antibody-modified target plate and CIA

a CIA chemiluminescence ImmunoAssays

b MS MALDI MS based on antibody-modified target plate